کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2402544 1102809 2013 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Estimating health service utilization for treatment of pneumococcal disease: The case of Brazil
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی ایمونولوژی
پیش نمایش صفحه اول مقاله
Estimating health service utilization for treatment of pneumococcal disease: The case of Brazil
چکیده انگلیسی


• Estimating health services utilization (HSU) is critical in economic evaluation in health.
• HSU estimates must capture clinical practice variability and population's access to healthcare.
• Estimating HSU for pneumococcal disease poses different challenges to researchers.
• Estimating HSU for non-invasive disease is challenging, particularly for outpatients.
• National HIS are important and relevant sources of data for HSU estimation.

BackgroundHealth service utilization (HSU) is an essential component of economic evaluations of health initiatives. Defining HSU for cases of pneumococcal disease (PD) is particularly complex considering the varying clinical manifestations and diverse severity.ObjectiveWe describe the process of developing estimates of HSU for PD as part of an economic evaluation of the introduction of pneumococcal conjugate vaccine in Brazil.MethodsNationwide inpatient and outpatient HSU by children under-5 years with meningitis (PM), sepsis (PS), non-meningitis non-sepsis invasive PD (NMNS), pneumonia, and acute otitis media (AOM) was estimated. We assumed that all cases of invasive PD (PM, PS, and NMNS) required hospitalization. The study perspective was the health system, including both the public and private sectors. Data sources were obtained from national health information systems, including the Hospital Information System (SIH/SUS) and the Notifiable Diseases Information System (SINAN); surveys; and community-based and health care facility-based studies.ResultsWe estimated hospitalization rates of 7.69 per 100,000 children under-5 years for PM (21.4 for children <1 years of age and 4.3 for children aged 1–4 years), 5.89 for PS (20.94 and 2.17), and 4.01 for NMNS (5.5 and 3.64) in 2004, with an overall hospitalization rate of 17.59 for all invasive PD (47.27 and 10.11). The estimated incidence rate of all-cause pneumonia was 93.4 per 1000 children under-5 (142.8 for children <1 years of age and 81.2 for children aged 1–4 years), considering both hospital and outpatient care.DiscussionSecondary data derived from health information systems and the available literature enabled the development of national HSU estimates for PD in Brazil. Estimating HSU for noninvasive disease was challenging, particularly in the case of outpatient care, for which secondary data are scarce. Information for the private sector is lacking in Brazil, but estimates were possible with data from the public sector and national population surveys.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 31, Supplement 3, 2 July 2013, Pages C63–C71
نویسندگان
, , , , ,